217 related articles for article (PubMed ID: 32298128)
1. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.
Zhang J; Shi Q; Guo M; Liu Z; Cai T
Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128
[TBL] [Abstract][Full Text] [Related]
2. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide).
Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T
Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764
[TBL] [Abstract][Full Text] [Related]
3. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
6. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
7. Origin of enhanced crystal growth kinetics near Tg probed with indomethacin polymorphs.
Wu T; Yu L
J Phys Chem B; 2006 Aug; 110(32):15694-9. PubMed ID: 16898713
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control.
Xu T; Nahar K; Dave R; Bates S; Morris K
Pharm Res; 2018 May; 35(7):140. PubMed ID: 29748722
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.
Shi Q; Zhang C; Su Y; Zhang J; Zhou D; Cai T
Mol Pharm; 2017 Jul; 14(7):2262-2272. PubMed ID: 28548840
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles.
La SB; Okano T; Kataoka K
J Pharm Sci; 1996 Jan; 85(1):85-90. PubMed ID: 8926590
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mobility and Crystal Growth in Amorphous Binary Drug Delivery Systems: Effects of Low-Concentration Poly(Ethylene Oxide).
Shi Q; Cheng J; Li F; Xu J; Zhang C
AAPS PharmSciTech; 2020 Nov; 21(8):317. PubMed ID: 33175339
[TBL] [Abstract][Full Text] [Related]
12. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.
Chauhan H; Kuldipkumar A; Barder T; Medek A; Gu CH; Atef E
Pharm Res; 2014 Feb; 31(2):500-15. PubMed ID: 24122167
[TBL] [Abstract][Full Text] [Related]
13. Surface crystallization of indomethacin below Tg.
Wu T; Yu L
Pharm Res; 2006 Oct; 23(10):2350-5. PubMed ID: 16927184
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
15. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
Duong TV; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
Xiang TX; Anderson BD
J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
[TBL] [Abstract][Full Text] [Related]
17. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
Suzuki H; Iwata M; Ito M; Noguchi S
Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
[TBL] [Abstract][Full Text] [Related]
18. Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations : Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li.
Arnfast L; Kamruzzaman M; Löbmann K; Aho J; Baldursdottir S; Rades T; Rantanen J
Pharm Res; 2017 Dec; 34(12):2689-2697. PubMed ID: 28929263
[TBL] [Abstract][Full Text] [Related]
19. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
Crowley KJ; Zografi G
Pharm Res; 2003 Sep; 20(9):1417-22. PubMed ID: 14567636
[TBL] [Abstract][Full Text] [Related]
20. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
